Ricardo Campello, partner, is going to be a speaker at the “Biosimilars LatAm – Brazil 2024”, which will take place on August 21 and 22, in São Paulo, Brazil. The event aims to delve into the hurdles of producing monoclonal antibodies locally, discuss effective strategies for navigating the complex landscape of biosimilar licensing in Brazil, and explore the economic implications of biosimilar usage, focusing on cost savings, accessibility, and the evolving market dynamics in the country. Learn more at: https://jackleckerman.com/events/biosimilars-latam-brazil-2024/